Our Mission:  To develop drug therapies for preventing and treating cognitive impairment and pain caused by inflammation.


Brain Inflammation: Pain, cognitive impairment and memory loss associated with brain inflammation

  • Major causes of serious health problems

  • • Highly comorbid with diseases such as heart disease, diabetes, arthritis, cancer and trauma

  • • Decreased quality of life and their ability to care for themselves and maintain independence

  • Major stress and secondary financial impacts on family members

  • • Significant societal costs due to cost of care and lost work productivity

Company: ProNeurogen is an early-stage biotech company founded in 2013 out of the University of Arizona.

Exclusive licensee of the technology

Protected by strong intellectual property including 3 patents issued in 2017. 

Game-changing, first-in-class and disruptive technologies.